Inhibition of connexin43 improves functional recovery after ischemic brain injury in neonatal rats

GLIA

Volumn 63, Issue 9, 2015, Pages 1553-1567

  Li, Xiaojing ^a,b   Zhao, Heqing ^a   Tan, Xianxing ^a,b   Kostrzewa, Richard M ^c   Du, Gang ^a,b   Chen, Yuanyuan ^a,b   Zhu, Jiangtao ^a   Miao, Zhigang ^b   Yu, Hailong ^d   Kong, Jiming ^e   Xu, Xingshun ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c East Tennessee State University   (United States)

^d NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Astrocyte; Caspase 3; Connexin43; Glutamate; Ischemic brain injury

Indexed keywords

CASPASE 3; CONNEXIN 43; GLUTAMIC ACID; SERINE; CONNEXIN 43 PROTEIN, RAT; GAP 26 PEPTIDE; GAP 27 PEPTIDE; GAP JUNCTION PROTEIN; GLUCOSE; NEUROPROTECTIVE AGENT; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; MOTOR CONTROL; MUSCLE STRENGTH; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; SPATIAL MEMORY; ANIMAL; ANOXIA; ANTAGONISTS AND INHIBITORS; BRAIN; CELL CULTURE; CELL HYPOXIA; CONVALESCENCE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GLIOSIS; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; ASTROCYTES; BRAIN; BRAIN ISCHEMIA; CELL HYPOXIA; CELLS, CULTURED; CONNEXIN 43; CONNEXINS; DISEASE MODELS, ANIMAL; GLIOSIS; GLUCOSE; GLUTAMIC ACID; MOTOR ACTIVITY; MUSCLE STRENGTH; NEUROPROTECTIVE AGENTS; PEPTIDES; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPATIAL MEMORY;

EID: 84949109724     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22826     Document Type: Article

References (64)

1. Anderson CM, Swanson RA. 2000. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions. Glia 32:1-14.
2. Bao X, Lee SC, Reuss L, Altenberg GA. 2007. Change in permeant size selectivity by phosphorylation of connexin 43 gap-junctional hemichannels by PKC. Proc Natl Acad Sci USA 104:4919-4924.
3. Batra N, Riquelme MA, Burra S, Jiang JX. 2014. 14-3-3theta facilitates plasma membrane delivery and function of mechanosensitive connexin 43 hemichannels. J Cell Sci 127:137-146.
4. Braet K, Aspeslagh S, Vandamme W, Willecke K, Martin PE, Evans WH, Leybaert L. 2003. Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1, 4, 5-trisphosphate and zero extracellular calcium in brain endothelial cells. J Cell Physiol 197:205-213.
5. Chen G, Park CK, Xie RG, Berta T, Nedergaard M, Ji RR. 2014. Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice. Brain 137:2193-2209.
6. Chever O, Lee CY, Rouach N. 2014. Astroglial connexin43 hemichannels tune basal excitatory synaptic transmission. J Neurosci 34:11228-11232.
7. Chew SS, Johnson CS, Green CR, Danesh-Meyer HV. 2010. Role of connexin43 in central nervous system injury. Exp Neurol 225:250-261.
8. Contreras JE, Sanchez HA, Veliz LP, Bukauskas FF, Bennett MV, Saez JC. 2004. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev 47:290-303.
9. D'Hooge R, De Deyn PP. 2001. Applications of the morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60-90.
10. Danesh-Meyer HV, Kerr NM, Zhang J, Eady EK, O'Carroll SJ, Nicholson LF, Johnson CS, Green CR. 2012. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain 135:506-520.
11. Dang X, Doble BW, Kardami E. 2003. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol Cell Biochem 242:35-38.
12. Dang X, Jeyaraman M, Kardami E. 2006. Regulation of connexin-43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming ability. Mol Cell Biochem 289:201-207.
13. Davidson JO, Green CR, Bennet L, Nicholson LF, Danesh-Meyer H, O'Carroll SJ, Gunn AJ. 2013. A key role for connexin hemichannels in spreading ischemic brain injury. Curr Drug Targets 14:36-46.
14. Decrock E, Vinken M, De Vuyst E, Krysko DV, D'Herde K, Vanhaecke T, Vandenabeele P, Rogiers V, Leybaert L. 2009. Connexin-related signaling in cell death: to live or let die? Cell Death Differ 16:524-536.
15. Deng ZH, Liao J, Zhang JY, Liang C, Song CH, Han M, Wang LH, Xue H, Zhang K, Zabeau L, Tavernier J, Yan GT . 2014. Inhibition of the connexin 43 elevation may be involved in the neuroprotective activity of leptin against brain ischemic injury. Cell Mol Neurobiol 34:871-879.
16. Dunn CA, Lampe PD. 2014. Injury-triggered akt phosphorylation of cx43: A ZO-1-driven molecular switch that regulates gap junction size. J Cell Sci 127:455-464.
17. Evans WH, De Vuyst E, Leybaert L. 2006. The gap junction cellular internet: Connexin hemichannels enter the signalling limelight. Biochem J 397:1-14.
18. Froger N, Orellana JA, Calvo CF, Amigou E, Kozoriz MG, Naus CC, Saez JC, Giaume C. 2010. Inhibition of cytokine-induced connexin43 hemichannel activity in astrocytes is neuroprotective. Mol Cell Neurosci 45:37-46.
19. Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A. 2007. Glia: The fulcrum of brain diseases. Cell Death Differ 14:1324-1335.
20. Goodenough DA, Paul DL. 2003. Beyond the gap: Functions of unpaired connexon channels. Nat Rev Mol Cell Biol 4:285-294.
21. Haupt C, Witte OW, Frahm C. 2007. Up-regulation of connexin43 in the glial scar following photothrombotic ischemic injury. Mol Cell Neurosci 35:89-99.
22. Hawat G, Helie P, Baroudi G. 2012. Single intravenous low-dose injections of connexin 43 mimetic peptides protect ischemic heart in vivo against myocardial infarction. J Mol Cell Cardiol 53:559-566.
23. Hertzberg EL, Saez JC, Corpina RA, Roy C, Kessler JA. 2000. Use of antibodies in the analysis of connexin 43 turnover and phosphorylation. Methods 20:129-139.
24. Hunter AW, Barker RJ, Zhu C, Gourdie RG. 2005. Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion. Mol Biol Cell 16:5686-5698.
25. Ishii Y, Shintani-Ishida K, Yoshida KI. 2013. Connexin-43 hemichannels contribute to the propagation of mu-calpain-mediated neuronal death in a cortical ablation injury model. Biochem Biophys Res Commun 441:457-462.
26. John SA, Kondo R, Wang SY, Goldhaber JI, Weiss JN. 1999. Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem 274:236-240.
27. Kirchhoff F, Dringen R, Giaume C. 2001. Pathways of neuron-astrocyte interactions and their possible role in neuroprotection. Eur Arch Psychiatry Clin Neurosci 251:159-169.
28. Kondo RP, Wang SY, John SA, Weiss JN, Goldhaber JI. 2000. Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes. J Mol Cell Cardiol 32:1859-1872.
29. Kumar NM, Gilula NB. 1996. The gap junction communication channel. Cell 84:381-388.
30. Laing JG, Tadros PN, Green K, Saffitz JE, Beyer EC. 1998. Proteolysis of connexin43-containing gap junctions in normal and heat-stressed cardiac myocytes. Cardiovasc Res 38:711-718.
31. Lee SR, Wang X, Tsuji K, Lo EH. 2004. Extracellular proteolytic pathophysiology in the neurovascular unit after stroke. Neurol Res 26:854-861.
32. Leithe E, Rivedal E. 2004. Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43. J Cell Sci 117:1211-1220.
33. Leybaert L, Braet K, Vandamme W, Cabooter L, Martin PE, Evans WH. 2003. Connexin channels, connexin mimetic peptides and ATP release. Cell Commun Adhes 10:251-257.
34. Liao CK, Cheng HH, Wang SD, Yeih DF, Wang SM. 2013. PKCvarepsilon mediates serine phosphorylation of connexin43 induced by lysophosphatidylcholine in neonatal rat cardiomyocytes. Toxicology 314:11-21.
35. Malarkey EB, Parpura V. 2008. Mechanisms of glutamate release from astrocytes. Neurochem Int 52:142-154.
36. Martin PE, Wall C, Griffith TM. 2005. Effects of connexin-mimetic peptides on gap junction functionality and connexin expression in cultured vascular cells. Br J Pharmacol 144:617-627.
37. Nagy JI, Rash JE. 2000. Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Brain Res Rev 32:29-44.
38. Nakase T, Fushiki S, Naus CC. 2003. Astrocytic gap junctions composed of connexin 43 reduce apoptotic neuronal damage in cerebral ischemia. Stroke 34:1987-1993.
39. Nakase T, Yoshida Y, Nagata K. 2006. Enhanced connexin 43 immunoreactivity in penumbral areas in the human brain following ischemia. Glia 54:369-375.
40. Nishizawa Y. 2001. Glutamate release and neuronal damage in ischemia. Life Sci 69:369-381.
41. O'Carroll SJ, Gorrie CA, Velamoor S, Green CR, Nicholson LF. 2013. Connexin43 mimetic peptide is neuroprotective and improves function following spinal cord injury. Neurosci Res 75:256-267.
42. O'Quinn MP, Palatinus JA, Harris BS, Hewett KW, Gourdie RG. 2011. A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury. Circ Res 108:704-715.
43. Orellana JA, Hernandez DE, Ezan P, Velarde V, Bennett MV, Giaume C, Saez JC. 2010. Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of connexin 43 hemichannels. Glia 58:329-343.
44. Orellana JA, Saez PJ, Shoji KF, Schalper KA, Palacios-Prado N, Velarde V, Giaume C, Bennett MV, Saez JC. 2009. Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid Redox Signal 11:369-399.
45. Park DJ, Freitas TA, Wallick CJ, Guyette CV, Warn-Cramer BJ. 2006. Molecular dynamics and in vitro analysis of connexin43: A new 14-3-3 mode-1 interacting protein. Protein Sci 15:2344-2355.
46. Park DJ, Wallick CJ, Martyn KD, Lau AF, Jin C, Warn-Cramer BJ. 2007. Akt phosphorylates connexin43 on ser373, a "mode-1" binding site for 14-3-3. Cell Commun Adhes 14:211-226.
47. Paxinos G, Franklin KBJ. 2008. The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
48. Plotkin LI, Manolagas SC, Bellido T. 2002. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 277:8648-8657.
49. Quist AP, Rhee SK, Lin H, Lal R. 2000. Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation. J Cell Biol 148:1063-1074.
50. Rhett JM, Jourdan J, Gourdie RG. 2011. Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1. Mol Biol Cell 22:1516-1528.
51. Schmitt M, Leykauf K, Reinz E, Cheng H, Alonso A, Schenkel J. 2014. Mutation of human connexin43 amino acids s279/s282 increases protein stability upon treatment with epidermal growth factor. Cell Biochem Biophys 69:379-384.
52. Smyth JW, Zhang SS, Sanchez JM, Lamouille S, Vogan JM, Hesketh GG, Hong T, Tomaselli GF, Shaw RM. 2014. A 14-3-3 mode-1 binding motif initiates gap junction internalization during acute cardiac ischemia. Traffic 15:684-699.
53. Sohl G, Maxeiner S, Willecke K. 2005. Expression and functions of neuronal gap junctions. Nat Rev Neurosci 6:191-200.
54. Spray DC, Ye ZC, Ransom BR. 2006. Functional connexin "hemichannels": A critical appraisal. Glia 54:758-773.
55. Stehberg J, Moraga-Amaro R, Salazar C, Becerra A, Echeverria C, Orellana JA, Bultynck G, Ponsaerts R, Leybaert L, Simon F, Sáez JC, Retamal MA. 2012. Release of gliotransmitters through astroglial connexin 43 hemichannels is necessary for fear memory consolidation in the basolateral amygdala. FASEB J 26:3649-3657.
56. Suzuki K, Ikegaya Y, Matsuura S, Kanai Y, Endou H, Matsuki N. 2001. Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes. J Cell Sci 114:3717-3725.
57. Swanson RA, Morton MT, Tsaowu G, Savalos RA, Davidson C, Sharp FR. 1990. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293.
58. Vergara L, Bao X, Bello-Reuss E, Reuss L. 2003. Do connexin 43 gap-junctional hemichannels activate and cause cell damage during ATP depletion of renal-tubule cells? Acta Physiol Scand 179:33-38.
59. Wang N, De Bock M, Decrock E, Bol M, Gadicherla A, Bultynck G, Leybaert L. 2013a. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered cx43 hemichannel opening. Neuropharmacology 75:506-516.
60. Wang X, Ma A, Zhu W, Zhu L, Zhao Y, Xi J, Zhang X, Zhao B. 2013b. The role of connexin 43 and hemichannels correlated with the astrocytic death following ischemia/reperfusion insult. Cell Mol Neurobiol 33:401-410.
61. Xu X, Chua CC, Kong J, Kostrzewa RM, Kumaraguru U, Hamdy RC, Chua BH. 2007. Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem 103:2004-2014.
62. Ye ZC, Wyeth MS, Baltan-Tekkok S, Ransom BR. 2003. Functional hemichannels in astrocytes: A novel mechanism of glutamate release. J Neurosci 23:3588-3596.
63. Yoon JJ, Green CR, O'Carroll SJ, Nicholson LF. 2010. Dose-dependent protective effect of connexin43 mimetic peptide against neurodegeneration in an ex vivo model of epileptiform lesion. Epilepsy Res 92:153-162.
64. Zhao Y, Rempe DA. 2010. Targeting astrocytes for stroke therapy. Neurotherapeutics 7:439-451.